Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Norris

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|June 1, 2002
Connections and regulation of the human estrogen receptorDonald P McDonnell, John D Norris
Elife|January 17, 2019
Targeting mutant estrogen receptorsSuzanne E Wardell, John D Norris, Donald P McDonnell
Cancer Cell|February 14, 2018
Neomorphic ERα Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug DiscoveryDonald P McDonnell, John D Norris, Ching-Yi Chang
Molecular Endocrinology (Baltimore, Md.)|July 30, 2002
Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonistsHuey-Jing Huang, John D Norris, Donald P McDonnell
Journal of Medicinal Chemistry|June 4, 2015
Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast CancerDonald P McDonnell, Suzanne E Wardell, John D Norris
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
A negative coregulator for the human ERJohn D Norris, Daju Fan, Andrea Sherk, et al.
The American Journal of Cardiology|July 11, 2002
Elucidation of the molecular mechanism of action of selective estrogen receptor modulatorsDonald P McDonnell, Ashini Wijayaratne, Ching-yi Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2021
Next-Generation Endocrine Therapies for Breast CancerDonald P McDonnell, Suzanne E Wardell, Ching-Yi Chang, et al.
Recent Progress in Hormone Research|May 23, 2002
Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulatorsDonald P McDonnell, Caroline E Connor, Ashini Wijayaratne, et al.
Methods in Enzymology|November 25, 2003
Application of random peptide phage display to the study of nuclear hormone receptorsChing-yi Chang, John D Norris, Michelle Jansen, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|June 1, 2002
Connections and regulation of the human estrogen receptorDonald P McDonnell, John D Norris
Elife|January 17, 2019
Targeting mutant estrogen receptorsSuzanne E Wardell, John D Norris, Donald P McDonnell
Cancer Cell|February 14, 2018
Neomorphic ERα Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug DiscoveryDonald P McDonnell, John D Norris, Ching-Yi Chang
Molecular Endocrinology (Baltimore, Md.)|July 30, 2002
Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonistsHuey-Jing Huang, John D Norris, Donald P McDonnell
Journal of Medicinal Chemistry|June 4, 2015
Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast CancerDonald P McDonnell, Suzanne E Wardell, John D Norris
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
A negative coregulator for the human ERJohn D Norris, Daju Fan, Andrea Sherk, et al.
The American Journal of Cardiology|July 11, 2002
Elucidation of the molecular mechanism of action of selective estrogen receptor modulatorsDonald P McDonnell, Ashini Wijayaratne, Ching-yi Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2021
Next-Generation Endocrine Therapies for Breast CancerDonald P McDonnell, Suzanne E Wardell, Ching-Yi Chang, et al.
Recent Progress in Hormone Research|May 23, 2002
Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulatorsDonald P McDonnell, Caroline E Connor, Ashini Wijayaratne, et al.
Methods in Enzymology|November 25, 2003
Application of random peptide phage display to the study of nuclear hormone receptorsChing-yi Chang, John D Norris, Michelle Jansen, et al.
Pageof 4